To test the hypothesis that TCM cells (which should be CD62L+) generated after B/I activation are responsible for the efficacy of these cells at inducing tumor regression, we separated B/I activated and expanded 4T1 tDLN into CD62L+ and CD62L- fractions, using magnetic beads. Here, SELL is linked to neoplasm.